The generic versions of Topicort are expected to be released after 01 September, 2028 once the last patent expires.
desoximetasone, the active ingredient in Topicort, makes it an effective treatment for plaque psoriasis in patients 18 years of age or older.
Topicort has a total of 2 drug patents, none of which have expired. The expiration date of the last patent is on 01 September, 2028. Below are the details of the patent: